Bank of New York Mellon’s T2 Biosystems, Inc TTOO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-603
| Closed | -$27.7K | – | 4480 |
|
|
2023
Q1 | $27.7K | Hold |
603
| – | – | ﹤0.01% | 4271 |
|
|
2022
Q4 | $85.6K | Buy |
603
+495
| +458% | +$102K | ﹤0.01% | 4145 |
|
|
2022
Q3 | $61K | Buy |
108
+88
| +440% | +$57.9K | ﹤0.01% | 4291 |
|
|
2022
Q2 | $16K | Hold |
20
| – | – | ﹤0.01% | 4516 |
|
|
2022
Q1 | $51K | Hold |
20
| – | – | ﹤0.01% | 4517 |
|
|
2021
Q4 | $51K | Hold |
20
| – | – | ﹤0.01% | 4499 |
|
|
2021
Q3 | $90K | Hold |
20
| – | – | ﹤0.01% | 4351 |
|
|
2021
Q2 | $117K | Hold |
20
| – | – | ﹤0.01% | 4194 |
|
|
2021
Q1 | $159K | Sell |
20
-2
| -9% | -$21.2K | ﹤0.01% | 4103 |
|
|
2020
Q4 | $134K | Buy |
22
+14
| +175% | +$85.7K | ﹤0.01% | 4046 |
|
|
2020
Q3 | $58K | Hold |
8
| – | – | ﹤0.01% | 4005 |
|
|
2020
Q2 | $54K | Buy |
+8
| New | +$34K | ﹤0.01% | 3976 |
|
|
2020
Q1 | – | Sell |
-6
| Closed | -$36K | – | 4206 |
|
|
2019
Q4 | $36K | Hold |
6
| – | – | ﹤0.01% | 4134 |
|
|
2019
Q3 | $75K | Hold |
6
| – | – | ﹤0.01% | 4066 |
|
|
2019
Q2 | $51K | Sell |
6
-14
| -70% | -$164K | ﹤0.01% | 4118 |
|
|
2019
Q1 | $264K | Sell |
20
-1
| -5% | -$17K | ﹤0.01% | 3790 |
|
|
2018
Q4 | $312K | Buy |
21
+5
| +31% | +$117K | ﹤0.01% | 3689 |
|
|
2018
Q3 | $595K | Buy |
16
+2
| +14% | +$65.9K | ﹤0.01% | 3550 |
|
|
2018
Q2 | $556K | Buy |
14
+9
| +180% | +$342K | ﹤0.01% | 3590 |
|
|
2018
Q1 | $164K | Buy |
5
+3
| +150% | +$80.8K | ﹤0.01% | 3968 |
|
|
2017
Q4 | $44K | Hold |
2
| – | – | ﹤0.01% | 4220 |
|
|
2017
Q3 | $45K | Hold |
2
| – | – | ﹤0.01% | 4120 |
|
|
2017
Q2 | $36K | Sell |
2
-9
| -82% | -$180K | ﹤0.01% | 4175 |
|
|
2017
Q1 | $297K | Hold |
11
| – | – | ﹤0.01% | 3754 |
|
|
2016
Q4 | $296K | Buy |
11
+2
| +22% | +$61.6K | ﹤0.01% | 3788 |
|
|
2016
Q3 | $317K | Hold |
9
| – | – | ﹤0.01% | 3741 |
|
|
2016
Q2 | $348K | Buy |
9
+1
| +13% | +$45.1K | ﹤0.01% | 3686 |
|
|
2016
Q1 | $371K | Hold |
8
| – | – | ﹤0.01% | 3553 |
|
|
2015
Q4 | $425K | Buy |
8
+2
| +33% | +$108K | ﹤0.01% | 3598 |
|
|
2015
Q3 | $267K | Sell |
6
-1
| -14% | -$66.4K | ﹤0.01% | 3811 |
|
|
2015
Q2 | $601K | Hold |
7
| – | – | ﹤0.01% | 3570 |
|
|
2015
Q1 | $505K | Buy |
7
+4
| +133% | +$371K | ﹤0.01% | 3603 |
|
|
2014
Q4 | $316K | Hold |
3
| – | – | ﹤0.01% | 3769 |
|
|
2014
Q3 | $255K | Buy |
+3
| New | +$279K | ﹤0.01% | 3827 |
|
Other funds holding TTOO
GCP
SM
IWM
CSS
BBA
Bank of New York Mellon's TTOO Position: Q2 2023 in Review
Bank of New York Mellon sold out of T2 Biosystems, Inc (TTOO) in Q2 2023, closing a stake of 603 shares — an estimated $27.7K sold.
Bank of New York Mellon first reported a position in TTOO in Q3 2014 and held it in 34 quarters. The position peaked at $601K in Q2 2015. 28 funds tracked by Wall St. Rank hold TTOO as of Q2 2023.
- Bank of New York Mellon reported no remaining T2 Biosystems, Inc position as of Q2 2023 after selling out during the quarter.
- Bank of New York Mellon sold 603 T2 Biosystems, Inc shares in Q2 2023, an estimated $27.7K.
- Bank of New York Mellon first reported a position in T2 Biosystems, Inc in Q3 2014 and held it in 34 quarters.
- Bank of New York Mellon's T2 Biosystems, Inc position peaked at $601K in Q2 2015.
- 28 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q2 2023.
Based on Bank of New York Mellon's 13F filing for Q2 2023, filed 3 Aug 2023.